Executive Management

Eric I. Richman
President and Interim CEO

Mr. Richman has extensive experience in the development and commercialization of novel biotechnology-based therapeutics, including work at MedImmune, Inc. and Healthcare Ventures. Mr. Richman was part of the founding team at MedImmune, holding various administrative, financial, strategic planning, and marketing and international positions. Mr. Richman was responsible for the U.S. launch of MedImmune's first commercial product and was on the launch teams for its other products including international launch of SynagisŪ. Mr. Richman was a former Director of Lev Pharmaceuticals and serves as a Director of ADMA Biologics, Inc., and American Bank. Mr. Richman received a B.S. in Biomedical Science from the Sophie Davis School of Biomedical Education (CUNY Medical School) and a Masters of Business Administration from the American Graduate School of International Management.